BridgeBio Pharma (BBIO) EBIT Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | -1.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.52% |
| Dec 31, 2025 | 38.25% |
| Sep 30, 2025 | 24.28% |
| Jun 30, 2025 | 23.51% |
| Mar 31, 2025 | -30,529.15% |
| Dec 31, 2024 | -27.40% |
| Sep 30, 2024 | -21.60% |
| Jun 30, 2024 | -20.15% |
| Mar 31, 2024 | 100.27% |
| Dec 31, 2023 | -37.28% |
| Sep 30, 2023 | -22.13% |
| Jun 30, 2023 | -82.22% |
| Mar 31, 2023 | 27.36% |
| Dec 31, 2022 | 21.97% |
| Sep 30, 2022 | 13.63% |
| Jun 30, 2022 | 14.72% |
| Mar 31, 2022 | -3.69% |
| Dec 31, 2021 | -29.90% |
| Sep 30, 2021 | -24.65% |
| Jun 30, 2021 | 24.53% |
| Mar 31, 2021 | -63.44% |
| Dec 31, 2020 | -62.12% |
| Sep 30, 2020 | -119.94% |
| Jun 30, 2020 | -79.70% |
| Mar 31, 2020 | -60.76% |
| Dec 31, 2019 | -19.91% |
| Sep 30, 2019 | -31.54% |
| Jun 30, 2019 | -99.29% |